Latest News
Jun 16, 2026
Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH StudyPre-production, Engineering Run and GMP Manufacture of PRP in 2026 MELBOURNE, Australia, June 16, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a…
View All Press Releases